Metabolomics of mothers of children with autism, idiopathic developmental delay, and Down syndrome

Abstract Developmental delays have been associated with metabolic disturbances in children. Previous research in the childhood autism risk from genetics and the environment (CHARGE) case–control study identified neurodevelopment-related plasma metabolites in children, suggesting disturbances in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariana Parenti, Shannon Shoff, Jennie Sotelo-Orozco, Irva Hertz-Picciotto, Carolyn M. Slupsky
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-83587-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559450099384320
author Mariana Parenti
Shannon Shoff
Jennie Sotelo-Orozco
Irva Hertz-Picciotto
Carolyn M. Slupsky
author_facet Mariana Parenti
Shannon Shoff
Jennie Sotelo-Orozco
Irva Hertz-Picciotto
Carolyn M. Slupsky
author_sort Mariana Parenti
collection DOAJ
description Abstract Developmental delays have been associated with metabolic disturbances in children. Previous research in the childhood autism risk from genetics and the environment (CHARGE) case–control study identified neurodevelopment-related plasma metabolites in children, suggesting disturbances in the energy-related tricarboxylic acid (TCA) cycle and 1-carbon metabolism (1CM). Here, we investigated associations between children’s neurodevelopmental outcomes and their mothers’ plasma metabolite profiles in a subset of mother–child dyads from CHARGE, including those with autism spectrum disorder (ASD, n = 209), Down syndrome (DS, n = 76), idiopathic developmental delay (iDD, n = 64), and typically developed (TD, n = 185) controls. Multiple linear regression revealed associations between child neurodevelopmental outcomes and maternal plasma metabolites related to the TCA cycle, 1CM, and lipid metabolism. Despite profound metabolic disturbances in children with DS reported previously, few of these differences were observed in the mothers, which might reflect differences in gene dosage between children with DS and their euploid mothers. Notably differences in maternal metabolism related to ASD and iDD followed similar patterns of disturbance in previously reported metabolic signatures in children but were generally smaller in magnitude. Similar patterns of metabolic disturbances observed in mothers and their children with ASD or iDD could reflect shared genetic, mitochondrial, and/or environmental risk factors.
format Article
id doaj-art-90ff4fa8ff424be5a4f6f1e80daf4dca
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-90ff4fa8ff424be5a4f6f1e80daf4dca2025-01-05T12:29:47ZengNature PortfolioScientific Reports2045-23222024-12-011411910.1038/s41598-024-83587-xMetabolomics of mothers of children with autism, idiopathic developmental delay, and Down syndromeMariana Parenti0Shannon Shoff1Jennie Sotelo-Orozco2Irva Hertz-Picciotto3Carolyn M. Slupsky4Department of Nutrition, Department of Food Science and Technology, University of CaliforniaDepartment of Nutrition, Department of Food Science and Technology, University of CaliforniaDepartment of Public Health Sciences, University of CaliforniaDepartment of Public Health Sciences, University of CaliforniaDepartment of Nutrition, Department of Food Science and Technology, University of CaliforniaAbstract Developmental delays have been associated with metabolic disturbances in children. Previous research in the childhood autism risk from genetics and the environment (CHARGE) case–control study identified neurodevelopment-related plasma metabolites in children, suggesting disturbances in the energy-related tricarboxylic acid (TCA) cycle and 1-carbon metabolism (1CM). Here, we investigated associations between children’s neurodevelopmental outcomes and their mothers’ plasma metabolite profiles in a subset of mother–child dyads from CHARGE, including those with autism spectrum disorder (ASD, n = 209), Down syndrome (DS, n = 76), idiopathic developmental delay (iDD, n = 64), and typically developed (TD, n = 185) controls. Multiple linear regression revealed associations between child neurodevelopmental outcomes and maternal plasma metabolites related to the TCA cycle, 1CM, and lipid metabolism. Despite profound metabolic disturbances in children with DS reported previously, few of these differences were observed in the mothers, which might reflect differences in gene dosage between children with DS and their euploid mothers. Notably differences in maternal metabolism related to ASD and iDD followed similar patterns of disturbance in previously reported metabolic signatures in children but were generally smaller in magnitude. Similar patterns of metabolic disturbances observed in mothers and their children with ASD or iDD could reflect shared genetic, mitochondrial, and/or environmental risk factors.https://doi.org/10.1038/s41598-024-83587-x
spellingShingle Mariana Parenti
Shannon Shoff
Jennie Sotelo-Orozco
Irva Hertz-Picciotto
Carolyn M. Slupsky
Metabolomics of mothers of children with autism, idiopathic developmental delay, and Down syndrome
Scientific Reports
title Metabolomics of mothers of children with autism, idiopathic developmental delay, and Down syndrome
title_full Metabolomics of mothers of children with autism, idiopathic developmental delay, and Down syndrome
title_fullStr Metabolomics of mothers of children with autism, idiopathic developmental delay, and Down syndrome
title_full_unstemmed Metabolomics of mothers of children with autism, idiopathic developmental delay, and Down syndrome
title_short Metabolomics of mothers of children with autism, idiopathic developmental delay, and Down syndrome
title_sort metabolomics of mothers of children with autism idiopathic developmental delay and down syndrome
url https://doi.org/10.1038/s41598-024-83587-x
work_keys_str_mv AT marianaparenti metabolomicsofmothersofchildrenwithautismidiopathicdevelopmentaldelayanddownsyndrome
AT shannonshoff metabolomicsofmothersofchildrenwithautismidiopathicdevelopmentaldelayanddownsyndrome
AT jenniesoteloorozco metabolomicsofmothersofchildrenwithautismidiopathicdevelopmentaldelayanddownsyndrome
AT irvahertzpicciotto metabolomicsofmothersofchildrenwithautismidiopathicdevelopmentaldelayanddownsyndrome
AT carolynmslupsky metabolomicsofmothersofchildrenwithautismidiopathicdevelopmentaldelayanddownsyndrome